Tag Archives: Type 1 diabetes

M42’s Danat Al Emarat Hospital pioneers immunotherapy for Type 1 diabetes treatment in the region

  • Danat Al Emarat Hospital for Women & Children demonstrates success in using Teplizumab for Type 1 diabetes treatment in the UAE and wider region
  • Teplizumab is an immunotherapy drug designed to delay the onset of Type 1 diabetes (T1D) in those  who have a confirmed diagnosis of T1D without clinical symptoms, as determined through the assessment of beta-cell function
  • It is one of the biggest treatment breakthroughs for the chronic condition since the discovery of insulin more than 100 years ago
Continue reading M42’s Danat Al Emarat Hospital pioneers immunotherapy for Type 1 diabetes treatment in the region